% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{White:277882, author = {C. L. White and K. M. Kinross and M. K. Buntine and E. Rasouli and R. Strong and J. M. Jones and J. E. Cain and D. Sturm$^*$ and F. Sahm$^*$ and D. T. W. Jones$^*$ and S. M. Pfister$^*$ and T. Robertson and C. D'Arcy and M. L. Rodriguez and J. M. Dyke and R. Junckerstorff and D. D. Bhuva and M. J. Davis and P. Wood and T. Hassall and D. S. Ziegler and S. Kellie and G. McCowage and F. Alvaro and M. Kirby and J. A. Heath and K. Tsui and A. Dodgshun and D. D. Eisenstat and D.-A. Khuong-Quang and M. Wall and E. M. Algar and N. G. Gottardo and J. R. Hansford}, title = {{I}mplementation of {DNA} methylation array profiling in pediatric central nervous system tumors - the {AIM} {BRAIN} {P}roject: an {A}ustralian and {N}ew {Z}ealand {C}hildren's {H}aematology and {O}ncology ({ANZCHOG}) {G}roup study.}, journal = {The journal of molecular diagnostics}, volume = {25}, number = {10}, issn = {1525-1578}, address = {Amsterdam [u.a.]}, publisher = {Elsevier}, reportid = {DKFZ-2023-01550}, pages = {709-728}, year = {2023}, note = {2023 Oct;25(10):709-728}, abstract = {DNA methylation array profiling for classifying pediatric central nervous system (CNS) tumors is a valuable adjunct to histopathology. However, unbiased prospective and inter-laboratory validation studies have been lacking. The AIM BRAIN (AB) diagnostic trial involving 11 pediatric cancer centers in Australia and New Zealand was designed to test the feasibility of routine clinical testing and ran in parallel with the Molecular Neuropathology 2.0 (MNP2.0) study at Deutsches Krebsforschungszentrum (DKFZ) (German Cancer Centre Heidelberg, Germany). CNS tumors from 269 pediatric patients were prospectively tested on Illumina EPIC arrays including 104 cases co-enrolled on MNP2.0. Using MNP classifier versions 11b4 and 12.5, we report classifications with a probability score ≥ 0.90 in 176/265 $(66.4\%)$ and 213/269 $(79.2\%)$ cases, respectively. Significant diagnostic information was obtained in 130/176 $(74\%)$ (11b4) and 12/174 $(7\%)$ classifications were discordant with histopathology. Cases prospectively co-enrolled on MNP2.0 gave concordant classifications $(99\%)$ and score thresholds $(93\%),$ demonstrating excellent test reproducibility and sensitivity. Overall, DNA methylation profiling is a robust single work-flow technique with an acceptable diagnostic yield that is considerably enhanced by the extensive subgroup and copy number profile information generated by the platform. The platform has excellent test reproducibility and sensitivity and contributes significantly to CNS tumor diagnosis.}, cin = {B360 / HD01 / B300 / B062}, ddc = {610}, cid = {I:(DE-He78)B360-20160331 / I:(DE-He78)HD01-20160331 / I:(DE-He78)B300-20160331 / I:(DE-He78)B062-20160331}, pnm = {312 - Funktionelle und strukturelle Genomforschung (POF4-312)}, pid = {G:(DE-HGF)POF4-312}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:37517472}, doi = {10.1016/j.jmoldx.2023.06.013}, url = {https://inrepo02.dkfz.de/record/277882}, }